BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28287611)

  • 1. FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer.
    Chen S; Huang J; Liu Z; Liang Q; Zhang N; Jin Y
    Oncogenesis; 2017 Mar; 6(3):e300. PubMed ID: 28287611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin.
    Zhou C; Zhu X; Liu N; Dong X; Zhang X; Huang H; Tang Y; Liu S; Hu M; Wang M; Deng X; Li S; Zhang R; Huang Y; Lyu H; Xiao S; Luo S; Ali DW; Michalak M; Chen XZ; Wang Z; Tang J
    Signal Transduct Target Ther; 2023 Feb; 8(1):66. PubMed ID: 36797256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM83A has a pro-tumor function in ovarian cancer by affecting the Akt/Wnt/β-catenin pathway.
    Zhao J; Zhao F; Yang T; Tian S; Zhao M; Wang S; Yang X
    Environ Toxicol; 2022 Apr; 37(4):695-707. PubMed ID: 34931434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis.
    Zheng YW; Li ZH; Lei L; Liu CC; Wang Z; Fei LR; Yang MQ; Huang WJ; Xu HT
    Front Oncol; 2020; 10():180. PubMed ID: 32195172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM83A Promotes the Proliferative and Invasive Abilities of Cervical Cancer Cells via Epithelial-Mesenchymal Transition and the Wnt Signaling Pathway.
    Lan C; Liu CC; Nie XC; Lei L; Xiao ZX; Li MX; Tang XN; Jia MY; Xu HT
    J Cancer; 2021; 12(21):6320-6329. PubMed ID: 34659522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.
    Rong L; Li H; Li Z; Ouyang J; Ma Y; Song F; Chen Y
    Front Med (Lausanne); 2020; 7():608441. PubMed ID: 33344485
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ncRNA-mediated upregulation of
    Zou W; Wang H; Wu D; Wu Y; Zhou K; Lian Y; Chang G; Feng Y; Liang J; Huang G
    Front Endocrinol (Lausanne); 2023; 14():1093042. PubMed ID: 37065746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
    Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
    J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
    Park JW; Park JM; Park DM; Kim DY; Kim HK
    Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC.
    Zhou F; Geng J; Xu S; Meng Q; Chen K; Liu F; Yang F; Pan B; Yu Y
    Aging (Albany NY); 2019 Aug; 11(16):6069-6088. PubMed ID: 31444970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
    Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
    Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
    [No Abstract]   [Full Text] [Related]  

  • 15. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
    Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83A is a potential biomarker for breast cancer initiation.
    Marino N; German R; Podicheti R; Rockey P; Sandusky GE; Temm CJ; Nakshatri H; Addison RJ; Selman B; Althouse SK; Storniolo AMV
    Biomark Res; 2022 Feb; 10(1):8. PubMed ID: 35183258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.